Sven Klussmann

Direttore Tecnico/Scientifico/R&S presso NOXXON Pharma AG

Health Technology

Consumer Services

Posizioni attive di Sven Klussmann

Società	Posizione	Inizio	Fine
NOXXON Pharma AG NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.	Direttore Tecnico/Scientifico/R&S	01/01/1997	-
	Presidente	01/01/1997	16/11/2009

Società	Posizione	Inizio	Fine
TME PHARMA N.V.	Direttore Tecnico/Scientifico/R&S	01/01/1997	-
TME PHARMA N.V.	Fondatore	01/01/1997	-

Freie Universität Berlin

Undergraduate Degree

Distribuzione geografica

Germania

Posizioni

Settori

Health Technology	3
Consumer Services	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
TME PHARMA N.V.	Health Technology

Aziende private	1
NOXXON Pharma AG NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.	Health Technology

Aziende private

Health Technology